![](https://www.precisionvaccinations.com/sites/default/files/styles/article_metadata/public/unnamed-6.png)
RSV Vaccine Sales Forecast Reaches $2.2 Billion in 2024
(Precision Vaccinations News)The market research firm Airfinity Limited recently lowered its sales projections for Respiratory Syncytial Virus (RSV) vaccines for older adults in the United States from $4.7 billion annually to $1.7 billion by 2030. …